Online citations, reference lists, and bibliographies.
← Back to Search

The Effect Of Topical Cyclosporin A On The Elicitation Phase Of Allergic Contact Dermatitis

G. W. Cole, S. Shimomaye, M. Goodman
Published 1988 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The effect of cyclosporin A (CSA) on the elicitation phase of allergic contact dermatitis was investigated. Initially, the ability of CSA to penetrate normal human cadaver skin was determined using 3 different vehicles. 10% CSA in Labrafil was found to be the must effective combination at achieving skin penetration (0.33%). Patients with known contact sensitivities to a variety of allergens were selected. After a 48‐h pretreatment with 10% CSA in Labrafil, skin sites were exposed to the appropriate contact allergen. 72 h later, the development of an eczemutous patch test reaction was evaluated. Only 1 of 10 patients showed unequivocal signs of suppression of allergic contact dermatitis
This paper references



This paper is referenced by
10.1111/j.1365-2133.1990.tb01480.x
Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity
J. I. Duncan (1990)
10.1136/vr.152.24.739
Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats
D. Robson (2003)
10.1001/ARCHDERM.1989.01670220129025
Topical application of cyclosporine on guinea pig allergic contact dermatitis.
G. Lembo (1989)
10.1111/j.2042-7158.1994.tb03874.x
Effect of Topical Preparation of Mycophenolic Acid on Experimental Allergic Contact Dermatitis of Guinea‐pigs Induced by Dinitrofluorobenzene
Y. Shôji (1994)
10.1111/j.1600-0536.1992.tb00895.x
Effect of a new topical cyclosporin formulation on human allergic contact dermatitis
C. Surber (1992)
10.1111/j.1468-3083.1993.tb00036.x
Cyclosporin A in the treatment of severe allergic contact dermatitis
Laura Flori (1993)
10.3109/9780849375903-13
Getting the Dose Right in Dermatological Therapy
A. Davis (2007)
10.3109/09546639209092744
Topical cyclosporin A treatment in psoriasis and other dermatological diseases: Theoretical and practical aspects.
F. Heule (1992)
10.1111/j.1600-0536.1998.tb05917.x
Prevention of nickel‐induced allergic contact reactions with pentoxifylline
H. Sarıcaoğlu (1998)
10.2165/00044011-199500101-00006
Dermatological Uses of Cyclosporin
J. A. Stutz (1995)
10.1016/J.BMC.2005.02.049
Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight.
A. Billich (2005)
10.2310/6620.2009.09005
Patch‐Testing While on Systemic Immunosuppressants
D. Rosmarin (2009)
10.1016/J.IJPHARM.2004.01.016
Iontophoresis of lecithin vesicles of cyclosporin A.
R. Boinpally (2004)
10.1111/j.2042-7158.1996.tb03910.x
Evaluation of In‐vivo Transdermal Absorption of Cyclosporin with Absorption Enhancer Using Intradermal Microdialysis in Rats
M. Nakashima (1996)
Semantic Scholar Logo Some data provided by SemanticScholar